Results 211 to 220 of about 18,682 (303)

The Troll Is Weakened but Not yet Defeated: An Update on Cytomegalovirus Management in Transplantation From the International CMV Symposium 2025

Transplant Infectious Disease, EarlyView.
This review synthesizes discussions from the 2025 International CMV Symposium on translating three recently updated international guidelines into clinical practice across solid organ and hematopoietic stem cell transplantation, highlighting advances in risk‐stratified prevention, emerging therapies, immune monitoring, and persistent implementation ...
Camille N. Kotton, Martina Sester, Julian Torre‐Cisneros, The International CMV Symposium Faculty   +3 more
wiley   +1 more source

Regulatory T cells from concept to clinic: The 2025 Nobel Prize and its implications for immune-mediated diseases and cancer. [PDF]

Biomed J
Huang CH, Ku WT, Lin YC, Lin CY.
europepmc   +1 more source

Terasaki's seminal contributions in HLA and Organ Transplantation [PDF]

, 1999
Starzl, TE
core  

Derivation of embryonic stem cells across avian species. [PDF]

Nat Biotechnol
Chen X, Guo Z, Tong X, Wang X, Liu X, Nagai H, Wu P, Lu J, Huss D, Tran M, Readhead C, Wu C, Cao L, Huang Y, Zeng Z, Feng F, Adhami N, Mor S, Lansford R, Chuong CM, Sheng G, Lois C, Ying QL.   +22 more
europepmc   +1 more source

Establishment of rostrocaudal polarity in tectal primordium:engrailed expression and subsequent tectal polarity [PDF]

, 1991
Hama, C, Ichijo, H, Itasaki, N, Matsuno, T, Nakamura, H   +4 more
core  

Curing autoimmune diabetes in mice with islet and hematopoietic cell transplantation after CD117 antibody-based conditioning. [PDF]

J Clin Invest
Bhagchandani P, Ramos SA, Rodriguez B, Gu X, Pathak S, Zhou Y, Moon Y, Nourin N, Chang CA, Poyser J, Velasco BJ, Zhao W, Kwon HS, Rodriguez R, Burgos DM, Miranda MA, Meyer E, Shizuru JA, Kim SK.   +18 more
europepmc   +1 more source

When Does Human Life Begin?: The Final Answer [PDF]

, 2003
Kischer, C. Ward
core   +1 more source

Impaired hematopoiesis affects apheresis and CAR T‐cell product composition and treatment response

Transfusion, EarlyView.
Abstract Background Chimeric antigen receptor (CAR) T‐cell therapy has transformed the treatment of hematologic malignancies, but its success depends on obtaining sufficient CD3+ T‐cell yields during leukapheresis. This can be difficult in heavily pretreated patients, who often show leukopenia and reduced T‐cell fitness.
Hanna Kuhn, Felix Korell, Angela Hückelhoven‐Krauss, Brigitte Neuber, Miriam Stenzinger, Anita Ludwig‐Husemann, Maria‐Luisa Schubert, Patrick Derigs, Kiavasch Farid, Tim Sauer, Sandra Sauer, Carsten Müller‐Tidow, Peter Dreger, Michael Schmitt, Anita Schmitt   +14 more
wiley   +1 more source

Metformin alters mitochondria-related metabolism and enhances human oligodendrocyte function. [PDF]

Nat Commun
Kazakou NL, Bestard-Cuche N, Wagstaff LJ, Horan K, Seeker L, Bøstrand S, Fetit R, Smith RS, Pohl FB, Neumann B, Keeler P, Franklin RJM, Williams A.   +12 more
europepmc   +1 more source

The status of cell and gene therapy education in medical schools—An international survey

Transfusion, EarlyView.
Abstract Introduction Cell and gene therapy (CGT) has emerged as a distinct medical field with more than 50 “Food and Drug Administration (FDA)”‐approved products treating conditions from leukemia to sickle cell disease. Despite this therapeutic revolution and the field's inherent complexity, the status of CGT education in medical schools remains ...
Edina A. Wappler‐Guzzetta, Alexandra M. Tabacu, Elena Nedelcu   +2 more
wiley   +1 more source